Clinical trial
Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With…
NCT00355030 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00355030 |
|---|---|
| Title | Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature |
| Official title | Efficacy and Safety of Somatropin in Combination With Leuprorelin Compared to Somatropin Alone in Pubertal Children With Idiopathic Short Stature |
| Acronym | Phoenix |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Idiopathic Short Stature (ISS) |
| Intervention type | Drug |
| Interventions | somatropin, leuprorelin |
| Enrollment | 91 |
| Start date | Jun 1, 2006 |
| Primary completion | Jul 1, 2015 |
| Completion | Jul 1, 2015 |
| First posted | Jul 20, 2006 |
| Last update posted | Sep 30, 2019 |
| Countries | France, Netherlands |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: